These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16829703)

  • 1. Mild and short recurrence of type II amiodarone-induced thyrotoxicosis in three patients receiving amiodarone continuously for more than 10 years.
    Sato K; Shiga T; Matsuda N; Onoda N; Takano K; Hagiwara N; Kasanuki H
    Endocr J; 2006 Aug; 53(4):531-8. PubMed ID: 16829703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
    Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
    Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone-induced thyrotoxicosis in children and adolescents is a possible outcome in patients with low iodine intake.
    Hacihamdioğlu B; Berberoğlu M; Siklar Z; Savaş Erdeve S; Oçal G; Tutar E; Atalay S
    J Pediatr Endocrinol Metab; 2010 Apr; 23(4):363-8. PubMed ID: 20583541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone-Induced Thyrotoxicosis Recurrence After Amiodarone Reintroduction.
    Maqdasy S; Batisse-Lignier M; Auclair C; Desbiez F; Citron B; Thieblot P; Roche B; Lusson JR; Tauveron I
    Am J Cardiol; 2016 Apr; 117(7):1112-6. PubMed ID: 26853955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues in amiodarone-induced thyrotoxicosis: Update and review of the literature.
    Maqdasy S; Benichou T; Dallel S; Roche B; Desbiez F; Montanier N; Batisse-Lignier M; Tauveron I
    Ann Endocrinol (Paris); 2019 Feb; 80(1):54-60. PubMed ID: 30236455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone-induced thyrotoxicosis. A review.
    Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
    Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodine ablation of the thyroid to prevent recurrence of amiodarone-induced thyrotoxicosis in patients with resistant tachyarrhythmias.
    Hermida JS; Tcheng E; Jarry G; Moullart V; Arlot S; Rey JL; Delonca J; Schvartz C
    Europace; 2004 Mar; 6(2):169-74. PubMed ID: 15018878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
    Loy M; Perra E; Melis A; Cianchetti ME; Piga M; Serra A; Pinna G; Mariotti S
    Acta Radiol; 2007 Jul; 48(6):628-34. PubMed ID: 17611870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone-induced thyrotoxicosis associated with thyrotropin receptor antibody.
    Sato K; Yamazaki K; Kanaji Y; Ohnishi S; Kasanuki H; Demura H
    Thyroid; 1998 Dec; 8(12):1123-6. PubMed ID: 9920368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of amiodarone-induced thyrotoxicosis.
    Osman F; Franklyn JA; Sheppard MC; Gammage MD
    Circulation; 2002 Mar; 105(11):1275-7. PubMed ID: 11901034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Challenges in the management of amiodarone-induced thyrotoxicosis].
    Tauveron I; Batisse-Lignier M; Maqdasy S
    Presse Med; 2018 Sep; 47(9):746-756. PubMed ID: 30274916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone-induced thyroid dysfunction.
    Danzi S; Klein I
    J Intensive Care Med; 2015 May; 30(4):179-85. PubMed ID: 24067547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality.
    O'Sullivan AJ; Lewis M; Diamond T
    Eur J Endocrinol; 2006 Apr; 154(4):533-6. PubMed ID: 16556715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone-induced thyrotoxicosis suggestive of thyroid damage.
    Lambert M; Unger J; De Nayer P; Brohet C; Gangji D
    J Endocrinol Invest; 1990 Jun; 13(6):527-30. PubMed ID: 2258582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulsed intravenous methylprednisolone combined with oral steroids as a treatment for poorly responsive type 2 amiodarone-induced thyrotoxicosis.
    Campi I; Perego GB; Ravogli A; Groppelli A; Parati G; Persani L; Fugazzola L
    Eur J Endocrinol; 2019 Nov; 181(5):519-524. PubMed ID: 31536966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of amiodarone-induced thyrotoxicosis and hypothyroidism].
    Gerber H; Noth D
    Ther Umsch; 1999 Jul; 56(7):374-9. PubMed ID: 10434774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone-induced thyrotoxicosis late after amiodarone withdrawal.
    Yagishita A; Hachiya H; Kawabata M; Nakamura T; Sugiyama K; Tanaka Y; Sasano T; Isobe M; Hirao K
    Circ J; 2013; 77(12):2898-903. PubMed ID: 24042320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study.
    Bogazzi F; Bartalena L; Cosci C; Brogioni S; Dell'Unto E; Grasso L; Aghini-Lombardi F; Rossi G; Pinchera A; Braverman LE; Martino E
    J Clin Endocrinol Metab; 2003 May; 88(5):1999-2002. PubMed ID: 12727944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone and thyroid dysfunction.
    Padmanabhan H
    South Med J; 2010 Sep; 103(9):922-30. PubMed ID: 20689491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amiodarone treatment and thyroid disorders].
    Łacka K; Fraczek MM
    Pol Merkur Lekarski; 2013 Jul; 35(205):5-9. PubMed ID: 23984597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.